Hospices Need a ‘Huge Catapult’ to Replenish Workforce

If enacted, the recently reintroduced Palliative Care and Hospice Education Training Act (PCHETA) could make a dent in the recruitment barriers that hospices keep hitting. But clinical education will need a much larger boost to ensure a sustainable workforce, according to many providers.  The training issue is a serious impediment to hospice recruitment, as very […]

Amedisys Triples Hospice, Home Health Growth With More M&A on the Horizon

Amedisys, Inc. (NASDAQ: AMED) is seeing its hospice and home health growth rates tripling based on rising patient census and a robust acquisitions pipeline. Hospice remains at the core of the company’s M&A strategy; Amedisys expects to see activity pick up in the home health sector as well this year. Baton Rouge, La.-based Amedisys last […]

Brookdale’s Occupancy Rebound Could Bolster Hospice Business with HCA Deal Pending

An upswing in occupancy in Brookdale Senior Living (NYSE: BKD) facilities could bode well for the company’s hospice and home health business, which will soon transition to hospital system HCA Healthcare following completion of a $400 million transaction. HCA will assume 80% ownership of the segment with Brookdale retaining a 20% stake.  Senior living occupancy […]

Brookdale Achieves Hospice Growth Despite COVID-19 Obstacles

Rising volume in its hospice business helped deflect the impact of COVID-19 headwinds on Brookdale Senior Living’s (NYSE: BKD) Health Care Services Segment in the second quarter, which saw a sharp decline in home health admissions.  Home health admissions have been falling off industry-wide during the pandemic due to widespread limitations on elective procedures and […]

Amedisys Poised for COVID-19 Recovery, Further Hospice Growth

The Amedisys, Inc. (NASDAQ: AMED) hospice segment saw a drop in referrals and rising costs stemming from the COVID-19 pandemic during the first quarter of this year. Though the outbreak creates industry-wide uncertainty about the future, demographic tailwinds, de novo activity and acquisitions show promise for a strong recovery, including the company’s $235 million purchase […]